Crossmark

Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine

Published Print: 2022-01

Authors

Oshiro, Telma Miyuki http://orcid.org/0000-0002-8791-9233
da Silva, Lais Teodoro http://orcid.org/0000-0001-8542-802X
Ortega, Marina Mazzilli

Perazzio, Sandro Felix

Duarte, Alberto Jose da Silva

Carneiro-Sampaio, Magda
Funding

Funding for this research was provided by:

CAPES

CNPq

Fundação de Amparo à Pesquisa do Estado de São Paulo (2014 / 50489-9, 2016 / 25212-9)
License Information

Text and Data Mining valid from 2022-01-01

Version of Record valid from 2022-01-31
More Information

This article is maintained by: Elsevier

Article Title: Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2022.100007

Content Type: simple-article

Copyright: © 2022 HCFMUSP. Published by Elsevier España, S.L.U.

Document is current